Stay updated with breaking news from Davids Tierney. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Bank of America assumed coverage on shares of Catalyst Pharmaceuticals (NASDAQ:CPRX – Free Report) in a research note published on Thursday morning, MarketBeat Ratings reports. The brokerage issued a buy rating and a $23.00 price objective on the biopharmaceutical company’s stock. CPRX has been the topic of several other research reports. Cantor Fitzgerald boosted their […]
Clark Estates Inc. NY bought a new position in shares of Catalyst Pharmaceuticals, Inc. (NASDAQ:CPRX – Free Report) during the 3rd quarter, according to its most recent disclosure with the SEC. The institutional investor bought 188,000 shares of the biopharmaceutical company’s stock, valued at approximately $2,198,000. Clark Estates Inc. NY owned 0.18% of Catalyst Pharmaceuticals […]
CenterBook Partners LP grew its position in shares of Catalyst Pharmaceuticals, Inc. (NASDAQ:CPRX – Free Report) by 20.0% in the third quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The fund owned 13,577 shares of the biopharmaceutical company’s stock after acquiring an additional 2,259 shares during […]
Moody Aldrich Partners LLC lifted its stake in shares of Catalyst Pharmaceuticals, Inc. (NASDAQ:CPRX – Free Report) by 4.2% during the third quarter, HoldingsChannel.com reports. The fund owned 273,512 shares of the biopharmaceutical company’s stock after buying an additional 11,075 shares during the quarter. Moody Aldrich Partners LLC’s holdings in Catalyst Pharmaceuticals were worth $3,197,000 […]
Moody Aldrich Partners LLC raised its stake in Catalyst Pharmaceuticals, Inc. (NASDAQ:CPRX – Free Report) by 4.2% during the 3rd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The firm owned 273,512 shares of the biopharmaceutical company’s stock after buying an additional 11,075 shares during the quarter. Moody […]